Background: Clinical guidelines recommend regular screening for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) to monitor at-risk relatives, resulting in a significant burden on clinical resources. Prioritizing relatives on their probability of developing definite ARVC may provide more efficient patient care. Objective: Determine predictors and probability of ARVC development over time among at-risk relatives. Methods: We included 136 relatives (46% male, 25.5 (interquartile range (IQR):15.8-44.4) years) from the Netherlands ACM Registry without definite ARVC by 2010 Task Force Criteria (TFC). Phenotype was ascertained using electrocardiograms, Holter monitoring, and cardiac imaging. Subjects were divided into "possible ARVC" (only genetic/familial predisposition) and "borderline ARVC" (one minor TFC criterion plus genetic/familial predisposition). We performed Cox regression to determine predictors, and multi-state modeling to assess probability of ARVC development. Results were replicated in an unrelated Italian cohort (57% male, 37.0 (IQR:25.4-50.4) years). Results: At baseline, 93 (68%) had possible and 43 (32%) borderline ARVC. Follow-up was available for 123 (90%) relatives. After 8.1 (IQR:4.2-11.4) years, 41 (33%) developed definite ARVC. Independent of baseline phenotype, symptomatic subjects (p=0.014) and those 20-30 years old (p=0.002) had higher hazard of developing definite ARVC. Furthermore, borderline ARVC patients had higher probability of developing definite ARVC compared to possible patients (1-year probability: 13% vs. 0.6%; 3-year probability: 35% vs. 5%, p<0.01). External replication showed comparable results (p>0.05). Conclusion: Symptomatic relatives, those in 20-30 age range and with borderline ARVC have higher probability of developing definite ARVC. These patients may benefit from more frequent follow-up, while others may be monitored less often.

Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy / S.A. Muller, A. Gasperetti, L.P. Bosman, A.F. Schmidt, A.F. Baas, A.S. Amin, A.C. Houweling, A.A.M. Wilde, P. Compagnucci, M. Targetti, M. Casella, L. Calò, C. Tondo, P. van der Harst, F.W. Asselbergs, J. Peter van Tintelen, M.I.F.J. Oerlemans, A.S.J.M. Te Riele. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - (2023). [Epub ahead of print] [10.1016/j.jacc.2023.05.005]

Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy

A. Gasperetti
Secondo
;
C. Tondo;
2023

Abstract

Background: Clinical guidelines recommend regular screening for Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) to monitor at-risk relatives, resulting in a significant burden on clinical resources. Prioritizing relatives on their probability of developing definite ARVC may provide more efficient patient care. Objective: Determine predictors and probability of ARVC development over time among at-risk relatives. Methods: We included 136 relatives (46% male, 25.5 (interquartile range (IQR):15.8-44.4) years) from the Netherlands ACM Registry without definite ARVC by 2010 Task Force Criteria (TFC). Phenotype was ascertained using electrocardiograms, Holter monitoring, and cardiac imaging. Subjects were divided into "possible ARVC" (only genetic/familial predisposition) and "borderline ARVC" (one minor TFC criterion plus genetic/familial predisposition). We performed Cox regression to determine predictors, and multi-state modeling to assess probability of ARVC development. Results were replicated in an unrelated Italian cohort (57% male, 37.0 (IQR:25.4-50.4) years). Results: At baseline, 93 (68%) had possible and 43 (32%) borderline ARVC. Follow-up was available for 123 (90%) relatives. After 8.1 (IQR:4.2-11.4) years, 41 (33%) developed definite ARVC. Independent of baseline phenotype, symptomatic subjects (p=0.014) and those 20-30 years old (p=0.002) had higher hazard of developing definite ARVC. Furthermore, borderline ARVC patients had higher probability of developing definite ARVC compared to possible patients (1-year probability: 13% vs. 0.6%; 3-year probability: 35% vs. 5%, p<0.01). External replication showed comparable results (p>0.05). Conclusion: Symptomatic relatives, those in 20-30 age range and with borderline ARVC have higher probability of developing definite ARVC. These patients may benefit from more frequent follow-up, while others may be monitored less often.
ARVC; family screening; predictors; screening interval; ventricular arrhythmia
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
2023
18-mag-2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0735109723055432-main_compressed.pdf

Open Access dal 19/05/2024

Descrizione: Article
Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 674.01 kB
Formato Adobe PDF
674.01 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/970533
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 2
social impact